Ruti Levy

A new report points to a steady migration of jobs, research activity and decision-making centers abroad, even as high-tech remains the engine of Israel's economy Share to FacebookShare to X Article printing is available to subscribers only Print in a simple, ad-free format Subscribe Zen reading is available to subscribers only Ad-free and in a comfortable reading format Subscribe 12:24 AM • June 01 2026 IDT For years, Israelis have measured the health of the local high-tech sector through...

The U.S. Food and Drug Administration has approved Israel-founded company Novocure to market a wearable device for the treatment of advanced pancreatic cancer, one of the deadliest forms of the disease. The device, Optune Pax, uses high-frequency electric fields and is designed to be used in combination with standard chemotherapy drugs gemcitabine and nab-paclitaxel. The electrical treatment not only extended patients' lives on average, but also delayed the worsening of pain by about six months.

The Weizmann Institute and Ben-Gurion University suffered catastrophic damage from Iranian missile strikes. Buildings collapsed, irreplaceable research samples were destroyed, and entire colonies of lab animals were lost.